<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02019537</url>
  </required_header>
  <id_info>
    <org_study_id>BRM-13-01</org_study_id>
    <nct_id>NCT02019537</nct_id>
  </id_info>
  <brief_title>Subacromial Injection of Allogeneic Platelet Rich Plasma (PRP) for Shoulder Impingement Syndrome</brief_title>
  <official_title>Allogeneic Platelet-Rich Plasma Versus Corticosteroid Injection for the Treatment of Rotator Cuff Disease: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the efficacy of allogeneic PRP in patients with&#xD;
      subacromial impingement disease&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety determined with symptoms &amp; signs of infection and immune response and adverse events evaluated with NCI-CTCAE v3.0</measure>
    <time_frame>Postinjection 1month</time_frame>
    <description>Presence of general symptoms or signs associated with infection and immune response, such as rash, pruritus, fever, chills, urticaria, or dyspnea.&#xD;
Injection sites were examined to identify erythema, swelling, or abnormal discharge.&#xD;
Adverse events were categorised with use of the National Cancer Institute Common Terminology Criteria for Adverse Events scale, version 3.0.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Constant-Murley score</measure>
    <time_frame>Postinjection 1month</time_frame>
    <description>The Constant-Murley score (CMS) is a 100-points scale composed of parameters defining the level of pain and the ability of performing daily activities.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Shoulder Impingement Syndrome</condition>
  <arm_group>
    <arm_group_label>Steroid group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Triamcinolone injection group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Allogeneic PRP injection group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Steroid injection into the subacromial space</intervention_name>
    <description>Group: Steroid&#xD;
Total volume of injection drugs: 4ml(1ml of triamcinolone acetonide 40mg/ml + 3ml of 2% lidocaine)&#xD;
The number of injections : only once during the study period&#xD;
Injection site : subacromial space&#xD;
Material : 25-gauze spinal needle&#xD;
Subacromial injections were performed using ultrasonographic guidance.</description>
    <arm_group_label>Steroid group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Allogeneic PRP injection into the subacromial space</intervention_name>
    <description>Group: Allogeneic PRP&#xD;
Total volume of injection drugs: 4ml&#xD;
The number of injections : only once during the study period&#xD;
Injection site : subacromial space&#xD;
Material : 25-gauze spinal needle&#xD;
Subacromial injections were performed using ultrasonographic guidance.</description>
    <arm_group_label>PRP group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female 18 years of age and older&#xD;
&#xD;
          -  Patients who have unilateral shoulder pain.&#xD;
&#xD;
          -  Patients who have had pain at least for 3 months&#xD;
&#xD;
          -  To be included in the study- participants are required to have a &amp; b.(mentioned below)&#xD;
&#xD;
               1. Pain with one of the two tests&#xD;
&#xD;
                    -  Neer's sign: passive overpressure at full shoulder flexion with the scapula&#xD;
                       fixed&#xD;
&#xD;
                    -  Hawkins test: passive internal rotation at 90 degree of shoulder flexion in&#xD;
                       the scapular plane and in progressive degree of horizontal adduction&#xD;
&#xD;
               2. Pain with one of the two tests&#xD;
&#xD;
                    -  Painful arc: active shoulder abduction&#xD;
&#xD;
                    -  Jobe's test: The examiner passively elevates the patient's shoulder to 90&#xD;
                       degrees of abduction with internal rotation. The examiner then applies a&#xD;
                       downward pressure against the arm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who received any drug by subacromial injection for treatment within 3 months&#xD;
             prior to this enrollment.&#xD;
&#xD;
          -  Patients who have a history of shoulder trauma including dislocation- subluxation- and&#xD;
             fracture- breast cancer- or surgery around shoulder- neck and upper back&#xD;
&#xD;
          -  Patients who have a isolated acromioclavicular joint pathology&#xD;
&#xD;
          -  Patients who have a full-thickness rotator cuff tear (evidenced by MR or&#xD;
             ultrasonography)&#xD;
&#xD;
          -  Patients with symptomatic cervical spine disorders&#xD;
&#xD;
          -  Patients who have a History of allergic adverse reactions to corticosteroid&#xD;
&#xD;
          -  Patients are unable to give informed consent to participate in the study&#xD;
&#xD;
          -  Patients are unable to come into the clinic for regular follow-up&#xD;
&#xD;
          -  Patients with adhesive capsulitis- acromioclavicular arthropathy- polyarthritis-&#xD;
             infectious arthritis- rheumatoid arthritis or diagnosed fibromyalgia&#xD;
&#xD;
          -  Patients with concurrent bilateral shoulder pain&#xD;
&#xD;
          -  Patients with neurological deficit&#xD;
&#xD;
          -  Patients who have severely abnormal radiological findings including malignancy, severe&#xD;
             osteoarthritis of the glenohumeral joint, severe skeletal abnormalities decreasing the&#xD;
             subacromial space and etc.&#xD;
&#xD;
          -  Presence of shoulder pain with limitation of both active and passive movements of the&#xD;
             glenohumeral joint of 25% in at least 2 directions (abduction, flexion, external&#xD;
             rotation, internal rotation), as compared with the contralateral shoulder or with&#xD;
             normal values&#xD;
&#xD;
          -  Patients with Diabetes mellitus&#xD;
&#xD;
          -  Patients taking anticoagulants&#xD;
&#xD;
          -  Pregnant women or lactating mothers&#xD;
&#xD;
          -  Patients who are difficulty participating in data collection due to communication&#xD;
             problem and serious mental illness&#xD;
&#xD;
          -  Patients with serious condition which can affect this study such as severe&#xD;
             cardiovascular diseases- renal diseases- liver diseases- endocrine diseases- and&#xD;
             cancers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Joint &amp; Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 18, 2013</study_first_submitted>
  <study_first_submitted_qc>December 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2013</study_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyunchul Jo</investigator_full_name>
    <investigator_title>Associate Professor, SMG-SNU Boramae Medical Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Impingement Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

